CANCELLI, FRANCESCA
CANCELLI, FRANCESCA
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems. A multicentric propensity score-weighted observational cohort study
2024 Rando, Emanuele; Salvati, Federica; Sangiorgi, Flavio; Catania, Francesca; Leone, Elisa; Oliva, Alessandra; Di Gennaro, Francesco; Fiori, Barbara; Cancelli, Francesca; Figliomeni, Sara; Bobbio, Francesca; Sacco, Federica; Bavaro, Davide Fiore; Diella, Lucia; Belati, Alessandra; Saracino, Annalisa; Mastroianni, Claudio Maria; Fantoni, Massimo; Murri, Rita
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations
2023 Oliva, A; Al Ismail, D; Arcari, G; Miele, M C; Casali, E; Sacco, F; Volpicelli, L; De Angelis, M; Mascellino, M T; Cancelli, F; Raponi, G; Carattoli, A; Venditti, M
Challenges in the Clinical Management of {SARS}-{CoV}2-Infected Patients with Haematological Malignancies
2022 COGLIATI DEZZA, Francesco; Binetti, Erica; Pupo, Anita; Cancelli, Francesca; Russo, Gianluca; Oliva, Alessandra; Mastroianni, Claudio Maria
Clinical characteristics and risk factors for mortality in COVID-19 patients during the first wave of the COVID-19 pandemic in Rome, Italy: a single-center retrospective study
2022 Rando, Emanuele; Oliva, Alessandra; Cancelli, Francesca; D'Agostino, Claudia; Savelloni, Giulia; Ciardi, Maria Rosa; Ajassa, Camilla; Siccardi, Guido; Galardo, Gioacchino; Mastroianni, Claudio M
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study
2022 Oliva, A; Curtolo, A; Volpicelli, L; Cancelli, F; Borrazzo, C; Cogliati Dezza, F; Marcelli, G; Gavaruzzi, F; Di Bari, S; Ricci, P; Turriziani, O; Mastroianni, C M; Venditti, M
Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature
2020 Oliva, A.; Siccardi, G.; Migliarini, A.; Cancelli, F.; Carnevalini, M.; D'Andria, M.; Attilia, I.; Danese, V. C.; Cecchetti, V.; Romiti, R.; Ceccarelli, G.; Mastroianni, C. M.; Palange, P.; Venditti, M.
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature
2022 Oliva, Alessandra; Cancelli, Francesca; Brogi, Andrea; Curtolo, Ambrogio; Savelloni, Giulia; Siccardi, Guido; Marcelli, Giulia; Mazzuti, Laura; Ricci, Paolo; Turriziani, Ombretta; Antonelli, Guido; Venditti, Mario; Mastroianni, Claudio M
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study
2022 Oliva, A.; Curtolo, A.; Volpicelli, L.; Cancelli, F.; Borrazzo, C.; Cogliati Dezza, F.; Marcelli, G.; Gavaruzzi, F.; Di Bari, S.; Ricci, P.; Turriziani, O.; Mastroianni, C. M.; Venditti, M.
Curb-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with sars-cov-2 pneumonia
2021 Oliva, A.; Borrazzo, C.; Mascellino, M. T.; Curtolo, A.; Ismail, D. A.; Cancelli, F.; Galardo, G.; Bucci, T.; Ceccarelli, G.; D'Ettorre, G.; Pugliese, F.; Mastroianni, C. M.; Venditti, M.
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection
2021 COGLIATI DEZZA, Francesco; Oliva, A.; Cancelli, F.; Savelloni, G.; Valeri, S.; Mauro, V.; Calabretto, M.; Russo, G.; Venditti, M.; Turriziani, O.; Mastroianni, C. M.
Effect of n-acetylcysteine administration on 30-day mortality in critically ill patients with septic shock caused by carbapenem-resistant klebsiella pneumoniae and acinetobacter baumannii. A retrospective case-control study
2021 Oliva, A.; Bianchi, A.; Russo, A.; Ceccarelli, G.; Cancelli, F.; Aloj, F.; Fegatelli, D. A.; Mastroianni, C. M.; Venditti, M.
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value
2017 Oliva, A.; Scorzolini, L.; Cipolla, A.; Mascellino, M. T.; Cancelli, F.; Castaldi, D.; D'Abramo, A.; D'Agostino, C.; Russo, G.; Ciardi, M. R.; Mastroianni, C. M.; Vullo, V.
Low-grade endotoxemia and thrombosis in COVID-19
2021 Oliva, A.; Cammisotto, V.; Cangemi, R.; Ferro, D.; Miele, M. C.; De Angelis, M.; Cancelli, F.; Pignatelli, P.; Venditti, M.; Pugliese, F.; Mastroianni, C. M.; Violi, F.
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies. Results from the HM-COV 2.0 study
2023 Oliva, Alessandra; COGLIATI DEZZA, Francesco; Petrucci, Flavia; Romani, FRANCESCO EUGENIO; Morviducci, Matteo; Mirabelli, Flavio Marco; Cancelli, Francesca; Valeriani, Emanuele; Marcelli, Giulia; Pugliese, Francesco; Turriziani, Ombretta; Ricci, Paolo; Venditti, Mario; Palange, Paolo; Mastroianni, Claudio Maria
Prognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19
2022 Savelloni, G.; Gatto, M. C.; Cancelli, F.; Barbetti, A.; Dezza, F. C.; Franchi, C.; Carnevalini, M.; Galardo, G.; Bucci, T.; Alessandroni, M.; Pugliese, F.; Mastroianni, C. M.; Oliva, A.
Real-life experience in the use of ceftobiprole for the treatment of nosocomial pneumonia: a case series
2021 Oliva, A.; Savellon, G.; Cancelli, F.; Valeri, S.; Mauro, V.; Aronica, R.; Romani, F.; Mastroianni, C. M.
Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study
2022 COGLIATI DEZZA, Francesco; Oliva, Alessandra; Mauro, Vera; Romani, FRANCESCO EUGENIO; Aronica, Raissa; Savelloni, Giulia; Casali, Elena; Valeri, Serena; Cancelli, Francesca; Mastroianni, Claudio Maria
Role of double-carbapenem regimen in the treatment of infections due to carbapenemase producing carbapenem-resistant enterobacteriaceae: a single-center, observational study
2018 Cancelli, F; Oliva, A; De Angelis, M; Mascellino, M T; Mastroianni, C M; Vullo, V
Role of serum e-selectin as a biomarker of infection severity in coronavirus disease 2019
2021 Oliva, Alessandra; Rando, Emanuele; Al Ismail, Dania; De Angelis, Massimiliano; Cancelli, Francesca; Miele, Maria Claudia; Aronica, Raissa; Mauro, Vera; Di Timoteo, Federica; Loffredo, Lorenzo; Mastroianni, Claudio M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems. A multicentric propensity score-weighted observational cohort study | 2024 | Rando, Emanuele; Salvati, Federica; Sangiorgi, Flavio; Catania, Francesca; Leone, Elisa; Oliva, Alessandra; Di Gennaro, Francesco; Fiori, Barbara; Cancelli, Francesca; Figliomeni, Sara; Bobbio, Francesca; Sacco, Federica; Bavaro, Davide Fiore; Diella, Lucia; Belati, Alessandra; Saracino, Annalisa; Mastroianni, Claudio Maria; Fantoni, Massimo; Murri, Rita | |
| Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations | 2023 | Oliva, A; Al Ismail, D; Arcari, G; Miele, M C; Casali, E; Sacco, F; Volpicelli, L; De Angelis, M; Mascellino, M T; Cancelli, F; Raponi, G; Carattoli, A; Venditti, M | |
| Challenges in the Clinical Management of {SARS}-{CoV}2-Infected Patients with Haematological Malignancies | 2022 | COGLIATI DEZZA, Francesco; Binetti, Erica; Pupo, Anita; Cancelli, Francesca; Russo, Gianluca; Oliva, Alessandra; Mastroianni, Claudio Maria | |
| Clinical characteristics and risk factors for mortality in COVID-19 patients during the first wave of the COVID-19 pandemic in Rome, Italy: a single-center retrospective study | 2022 | Rando, Emanuele; Oliva, Alessandra; Cancelli, Francesca; D'Agostino, Claudia; Savelloni, Giulia; Ciardi, Maria Rosa; Ajassa, Camilla; Siccardi, Guido; Galardo, Gioacchino; Mastroianni, Claudio M | |
| Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study | 2022 | Oliva, A; Curtolo, A; Volpicelli, L; Cancelli, F; Borrazzo, C; Cogliati Dezza, F; Marcelli, G; Gavaruzzi, F; Di Bari, S; Ricci, P; Turriziani, O; Mastroianni, C M; Venditti, M | |
| Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature | 2020 | Oliva, A.; Siccardi, G.; Migliarini, A.; Cancelli, F.; Carnevalini, M.; D'Andria, M.; Attilia, I.; Danese, V. C.; Cecchetti, V.; Romiti, R.; Ceccarelli, G.; Mastroianni, C. M.; Palange, P.; Venditti, M. | |
| Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature | 2022 | Oliva, Alessandra; Cancelli, Francesca; Brogi, Andrea; Curtolo, Ambrogio; Savelloni, Giulia; Siccardi, Guido; Marcelli, Giulia; Mazzuti, Laura; Ricci, Paolo; Turriziani, Ombretta; Antonelli, Guido; Venditti, Mario; Mastroianni, Claudio M | |
| Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study | 2022 | Oliva, A.; Curtolo, A.; Volpicelli, L.; Cancelli, F.; Borrazzo, C.; Cogliati Dezza, F.; Marcelli, G.; Gavaruzzi, F.; Di Bari, S.; Ricci, P.; Turriziani, O.; Mastroianni, C. M.; Venditti, M. | |
| Curb-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with sars-cov-2 pneumonia | 2021 | Oliva, A.; Borrazzo, C.; Mascellino, M. T.; Curtolo, A.; Ismail, D. A.; Cancelli, F.; Galardo, G.; Bucci, T.; Ceccarelli, G.; D'Ettorre, G.; Pugliese, F.; Mastroianni, C. M.; Venditti, M. | |
| Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection | 2021 | COGLIATI DEZZA, Francesco; Oliva, A.; Cancelli, F.; Savelloni, G.; Valeri, S.; Mauro, V.; Calabretto, M.; Russo, G.; Venditti, M.; Turriziani, O.; Mastroianni, C. M. | |
| Effect of n-acetylcysteine administration on 30-day mortality in critically ill patients with septic shock caused by carbapenem-resistant klebsiella pneumoniae and acinetobacter baumannii. A retrospective case-control study | 2021 | Oliva, A.; Bianchi, A.; Russo, A.; Ceccarelli, G.; Cancelli, F.; Aloj, F.; Fegatelli, D. A.; Mastroianni, C. M.; Venditti, M. | |
| In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value | 2017 | Oliva, A.; Scorzolini, L.; Cipolla, A.; Mascellino, M. T.; Cancelli, F.; Castaldi, D.; D'Abramo, A.; D'Agostino, C.; Russo, G.; Ciardi, M. R.; Mastroianni, C. M.; Vullo, V. | |
| Low-grade endotoxemia and thrombosis in COVID-19 | 2021 | Oliva, A.; Cammisotto, V.; Cangemi, R.; Ferro, D.; Miele, M. C.; De Angelis, M.; Cancelli, F.; Pignatelli, P.; Venditti, M.; Pugliese, F.; Mastroianni, C. M.; Violi, F. | |
| Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies. Results from the HM-COV 2.0 study | 2023 | Oliva, Alessandra; COGLIATI DEZZA, Francesco; Petrucci, Flavia; Romani, FRANCESCO EUGENIO; Morviducci, Matteo; Mirabelli, Flavio Marco; Cancelli, Francesca; Valeriani, Emanuele; Marcelli, Giulia; Pugliese, Francesco; Turriziani, Ombretta; Ricci, Paolo; Venditti, Mario; Palange, Paolo; Mastroianni, Claudio Maria | |
| Prognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19 | 2022 | Savelloni, G.; Gatto, M. C.; Cancelli, F.; Barbetti, A.; Dezza, F. C.; Franchi, C.; Carnevalini, M.; Galardo, G.; Bucci, T.; Alessandroni, M.; Pugliese, F.; Mastroianni, C. M.; Oliva, A. | |
| Real-life experience in the use of ceftobiprole for the treatment of nosocomial pneumonia: a case series | 2021 | Oliva, A.; Savellon, G.; Cancelli, F.; Valeri, S.; Mauro, V.; Aronica, R.; Romani, F.; Mastroianni, C. M. | |
| Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study | 2022 | COGLIATI DEZZA, Francesco; Oliva, Alessandra; Mauro, Vera; Romani, FRANCESCO EUGENIO; Aronica, Raissa; Savelloni, Giulia; Casali, Elena; Valeri, Serena; Cancelli, Francesca; Mastroianni, Claudio Maria | |
| Role of double-carbapenem regimen in the treatment of infections due to carbapenemase producing carbapenem-resistant enterobacteriaceae: a single-center, observational study | 2018 | Cancelli, F; Oliva, A; De Angelis, M; Mascellino, M T; Mastroianni, C M; Vullo, V | |
| Role of serum e-selectin as a biomarker of infection severity in coronavirus disease 2019 | 2021 | Oliva, Alessandra; Rando, Emanuele; Al Ismail, Dania; De Angelis, Massimiliano; Cancelli, Francesca; Miele, Maria Claudia; Aronica, Raissa; Mauro, Vera; Di Timoteo, Federica; Loffredo, Lorenzo; Mastroianni, Claudio M |